These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 18240930)

  • 21. Genetic sub-types of human malignant astrocytoma correlate with survival.
    Leenstra S; Oskam NT; Bijleveld EH; Bosch DA; Troost D; Hulsebos TJ
    Int J Cancer; 1998 Apr; 79(2):159-65. PubMed ID: 9583731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
    Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
    Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic alterations associated with adult diffuse astrocytic tumors.
    Shapiro JR
    Am J Med Genet; 2002 Oct; 115(3):194-201. PubMed ID: 12407701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical utility of fluorescence in situ hybridization (FISH) in nonbrainstem glioblastomas of childhood.
    Korshunov A; Sycheva R; Gorelyshev S; Golanov A
    Mod Pathol; 2005 Sep; 18(9):1258-63. PubMed ID: 15832192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosome number and carmustine sensitivity in human gliomas.
    Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
    Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal analysis of human astrocytomas.
    Morse RP; Darras BT; Ye Z; Wu JK
    J Neurooncol; 1994; 21(2):151-7. PubMed ID: 7861191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of immunohistochemistry in predicting behavior of astrocytic tumors.
    Ambroise MM; Khosla C; Ghosh M; Mallikarjuna VS; Annapurneswari S
    Asian Pac J Cancer Prev; 2010; 11(4):1079-84. PubMed ID: 21133628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gain of chromosome 7, as detected by in situ hybridization, strongly correlates with shorter survival in astrocytoma grade 2.
    Wessels PH; Twijnstra A; Kessels AG; Krijne-Kubat B; Theunissen PH; Ummelen MI; Ramaekers FC; Hopman AH
    Genes Chromosomes Cancer; 2002 Mar; 33(3):279-84. PubMed ID: 11807985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas.
    Ransom DT; Ritland SR; Moertel CA; Dahl RJ; O'Fallon JR; Scheithauer BW; Kimmel DW; Kelly PJ; Olopade OI; Diaz MO
    Genes Chromosomes Cancer; 1992 Nov; 5(4):357-74. PubMed ID: 1283325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH).
    Fuller CE; Wang H; Zhang W; Fuller GN; Perry A
    J Neuropathol Exp Neurol; 2002 Dec; 61(12):1078-84. PubMed ID: 12484570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of novel genomic aberrations in anaplastic astrocytomas by GTG-banding, SKY, locus-specific FISH, and high density SNP-array.
    Holland H; Ahnert P; Koschny R; Kirsten H; Bauer M; Schober R; Meixensberger J; Fritzsch D; Krupp W
    Pathol Res Pract; 2012 Jun; 208(6):325-30. PubMed ID: 22575435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma.
    Perry A; Aldape KD; George DH; Burger PC
    Cancer; 2004 Nov; 101(10):2318-26. PubMed ID: 15470710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
    Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic alterations in pediatric high-grade astrocytomas.
    Cheng Y; Ng HK; Zhang SF; Ding M; Pang JC; Zheng J; Poon WS
    Hum Pathol; 1999 Nov; 30(11):1284-90. PubMed ID: 10571506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 and PTEN gene mutations in gemistocytic astrocytomas.
    Watanabe K; Peraud A; Gratas C; Wakai S; Kleihues P; Ohgaki H
    Acta Neuropathol; 1998 Jun; 95(6):559-64. PubMed ID: 9650746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 10q25.3 (DMBT1) copy number changes in astrocytoma grades II and IV.
    Wessels PH; Twijnstra A; Kubat B; Ummelen MI; Claessen SM; Sciot R; Merlo A; Ramaekers FC; Speel EJ; Hopman AH
    Genes Chromosomes Cancer; 2004 Jan; 39(1):22-8. PubMed ID: 14603438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular pathogenesis of malignant gliomas.
    Rasheed BK; Wiltshire RN; Bigner SH; Bigner DD
    Curr Opin Oncol; 1999 May; 11(3):162-7. PubMed ID: 10328589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intratumoral, not circulating, endothelial progenitor cells share genetic aberrations with glial tumor cells.
    Zheng PP; van der Weiden M; van der Spek PJ; Vincent AJ; Kros JM
    J Cell Physiol; 2013 Jul; 228(7):1383-90. PubMed ID: 23254765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic pathways to primary and secondary glioblastoma.
    Ohgaki H; Kleihues P
    Am J Pathol; 2007 May; 170(5):1445-53. PubMed ID: 17456751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.